In Vivo Renal Lipid Quantification by Accelerated Magnetic Resonance Spectroscopic Imaging at 3T: Feasibility and Reliability Study
dc.contributor.author | Alhulail, Ahmad A. | |
dc.contributor.author | Servati, Mahsa | |
dc.contributor.author | Ooms, Nathan | |
dc.contributor.author | Akin, Oguz | |
dc.contributor.author | Dincer, Alp | |
dc.contributor.author | Thomas, M. Albert | |
dc.contributor.author | Dydak, Ulrike | |
dc.contributor.author | Emir, Uzay E. | |
dc.contributor.department | Radiology and Imaging Sciences, School of Medicine | en_US |
dc.date.accessioned | 2023-06-16T16:38:14Z | |
dc.date.available | 2023-06-16T16:38:14Z | |
dc.date.issued | 2022-04-23 | |
dc.description.abstract | A reliable and practical renal-lipid quantification and imaging method is needed. Here, the feasibility of an accelerated MRSI method to map renal fat fractions (FF) at 3T and its repeatability were investigated. A 2D density-weighted concentric-ring-trajectory MRSI was used for accelerating the acquisition of 48 × 48 voxels (each of 0.25 mL spatial resolution) without respiratory navigation implementations. The data were collected over 512 complex-FID timepoints with a 1250 Hz spectral bandwidth. The MRSI sequence was designed with a metabolite-cycling technique for lipid-water separation. The in vivo repeatability performance of the sequence was assessed by conducting a test-reposition-retest study within healthy subjects. The coefficient of variation (CV) in the estimated FF from the test-retest measurements showed a high degree of repeatability of MRSI-FF (CV = 4.3 ± 2.5%). Additionally, the matching level of the spectral signature within the same anatomical region was also investigated, and their intrasubject repeatability was also high, with a small standard deviation (8.1 ± 6.4%). The MRSI acquisition duration was ~3 min only. The proposed MRSI technique can be a reliable technique to quantify and map renal metabolites within a clinically acceptable scan time at 3T that supports the future application of this technique for the non-invasive characterization of heterogeneous renal diseases and tumors. | en_US |
dc.eprint.version | Final published version | en_US |
dc.identifier.citation | Alhulail AA, Servati M, Ooms N, et al. In Vivo Renal Lipid Quantification by Accelerated Magnetic Resonance Spectroscopic Imaging at 3T: Feasibility and Reliability Study. Metabolites. 2022;12(5):386. Published 2022 Apr 23. doi:10.3390/metabo12050386 | en_US |
dc.identifier.uri | https://hdl.handle.net/1805/33820 | |
dc.language.iso | en_US | en_US |
dc.publisher | MDPI | en_US |
dc.relation.isversionof | 10.3390/metabo12050386 | en_US |
dc.relation.journal | Metabolites | en_US |
dc.rights | Attribution 4.0 International | * |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0 | * |
dc.source | PMC | en_US |
dc.subject | Kidney | en_US |
dc.subject | Renal | en_US |
dc.subject | Lipid | en_US |
dc.subject | Fast MRSI | en_US |
dc.title | In Vivo Renal Lipid Quantification by Accelerated Magnetic Resonance Spectroscopic Imaging at 3T: Feasibility and Reliability Study | en_US |
dc.type | Article | en_US |